^
BIOMARKER:
PALB2 mutation
i
Other names: PALB2, Partner And Localizer Of BRCA2, FANCN, Truncated Partner And Localizer Of BRCA2, Fanconi Anemia, Complementation Group N, Mutant Partner And Localizer Of BRCA2, PNCA3
Entrez ID:
PALB2 mutation
Pancreatic Cancer
rucaparib
Sensitive
:
C2
J Clin Oncol - 2d
PALB2 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
A2
PALB2 mutation
Prostate Cancer
olaparib
Sensitive
:
A2
PALB2 mutation
Pancreatic Cancer
ABT-888
Sensitive
:
C2
PALB2 mutation
HER2 Negative Breast Cancer
talazoparib
Sensitive
:
C2
PALB2 mutation
Breast Cancer
olaparib
Sensitive
:
C2
PALB2 mutation
Urothelial Cancer
olaparib
Sensitive
:
C2
PALB2 mutation
HER2 Negative Breast Cancer
durvalumab
Sensitive
:
C2
PALB2 mutation
Triple Negative Breast Cancer
everolimus
Sensitive
:
C3
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
PALB2 mutation
Hormone Receptor Positive Breast Cancer
lenvatinib
Resistant
:
C3
PALB2 mutation
Pancreatic Cancer
oxaliplatin
Sensitive
:
C3
PALB2 mutation
Prostate Cancer
PARP inhibitor
Sensitive
:
C3
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
C3
PALB2 mutation
Triple Negative Breast Cancer
carboplatin + docetaxel
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our